Genomics research: New genetic 'hit list' may underlie susceptibility to sudden cardiac death

December 30, 2003

ROCHESTER, Minn. -- Researchers at Mayo Clinic have discovered that genetic variants associated with instances of sudden cardiac deaths are far more prevalent and diverse than first thought -- especially among minorities. The news comes from a study on a specific cardiac disorder affecting young people -- long QT syndrome -- which may kill as many as 3,000 teenagers and young adults in the United States annually.

"These findings are critical for the proper interpretation of genetic tests for diagnosing long QT syndrome," says principal author Michael Ackerman, M.D., Ph.D. "This extensive data set will aid in that interpretation and help investigators explore whether any of these new variants increase susceptibility to sudden cardiac death, which claims 350,000 lives each year."

The findings are published in the December issue of Mayo Clinic Proceedings (Mayo Clin Proc. 2003;78:1479-1487).

Long QT syndrome results from a primary genetic glitch involving the heart's electrical system and can cause episodes of fainting, seizing or sudden death. Its presence can often be detected with an electrocardiogram (ECG) where the interval between points Q and T is abnormally prolonged. If untreated, half the people with symptomatic long QT syndrome will die within ten years after the first symptoms are noticed.

First Genomics Analysis of Healthy Population

Mayo researchers conducted a comprehensive DNA analysis of 744 healthy volunteers from among four ethnic groups. This study group was unusual, not only for its size compared to previous studies, but because it included sufficient numbers of minorities to make findings statistically significant for those subgroups. The study included 305 black, 187 white, 134 Asian and 118 Hispanic individuals. Previous studies examined groups that included only long QT patients and their families, looking for genetic variants that cause this inherited syndrome. This Mayo-led study is the first comprehensive analysis of a large group of healthy persons for gene mutations that could increase susceptibility to sudden cardiac death.

Surprising Prevalence of Variants

Inherited long QT syndrome occurs when a defect develops in one or more of the genes that program the ion channels of the heart. The ion channels are "electrical tunnels" that produce and control the heart's electrical activity. A key finding of this study: far more potassium channel variants exist than were anticipated. The study identified 49 distinct variants among the healthy population examined -- 36 of the variants or 73 percent were previously unknown. Eighty-six percent of the variants were found only in specific ethnic groups. When researchers excluded the most common and established potassium channel variants, one in three blacks and one in seven whites studied were found to harbor at least one variant. Based on previous studies, a potassium channel mutation causing inherited long QT syndrome should be expected in only one out of every 10,000 individuals.

Impacts Future Diagnosis for Blacks

The researchers say the findings have a profound impact on diagnosis and future testing for long QT syndrome. Because of the large number of variants found in such a diverse, healthy group of individuals, researchers say physicians need to use extreme care in diagnosing newly-discovered variants as disease-causing mutations -- especially among minority patients.

"This new compendium of channel variants is a 'hit list' of suspects for investigators aiming at the larger issue of sudden cardiac death," says Dr. Ackerman. "We don't know if any of these variants cause increased susceptibility to external causes, such as medications, but the new data provides an exciting opportunity for important studies."

For example, one variant -- Q9E-MiRP1 -- previously identified as a disease-causing arrhythmia mutation -- had not been seen in over one thousand control subjects. Yet this study showed that Q9E-MiRP1 is present in about five percent of blacks and therefore could predispose thousands of minority individuals to drug-induced sudden death.

Previous study methods would have inappropriately labeled nearly all 36 newly-identified variants as disease-causing mutations. More research must be done to determine if the higher frequency of channel variants indicates an increased risk for fatal arrhythmias.

Co-authors of the article include David Tester and Melissa Will, Mayo Clinic, and Christopher Burrow, M.D., Mark Curran, Ph.D., and Gregg Jones, formerly of DNA Sciences, Inc., Fremont, Calif.

Mayo Clinic conducts research in medical genomics and proteomics in order to improve patient care. Its scientists and clinical investigators strive to turn laboratory discoveries into beneficial therapies as quickly as possible. Patient privacy and confidentiality in research studies are ensured.
-end-


Mayo Clinic

Related Genetic Variants Articles from Brightsurf:

Researchers identify genetic variants linked to toxic side effects from bevacizumab
In the largest study of its kind, researchers have found two common genetic variants that can be used to predict whether or not cancer patients might suffer severe adverse side-effects, such as high blood pressure, from the drug bevacizumab.

Genetic risk of developing obesity is driven by variants that affect the brain
Some people are at higher risk of developing obesity because they possess genetic variants that affect how the brain processes sensory information and regulates feeding and behavior.

Genetic background influences disease risk from single-gene variants
Life can change dramatically when someone learns they are genetically predisposed to a disease.

Researchers identify novel genetic variants linked to type-2 diabetes
After examining the genes of more than 200,000 people all over the world who have type-2 diabetes, researchers from the Perelman School of Medicine at the University of Pennsylvania and the Veterans Health Administration's Corporal Michael J.

FSU researchers help discover new genetic variants that cause heart disease in infants
Florida State University researchers working in an international collaboration have identified new genetic variants that cause heart disease in infants, and their research has led to novel insights into the role of a protein that affects how the heart pumps blood.

Twenty four genetic variants linked to heightened womb cancer risk
Twenty four common variations in genes coding for cell growth and death, the processing of oestrogen, and gene control factors may be linked to a heightened risk of developing womb (endometrial) cancer, indicates the most comprehensive review of the published evidence so far in the Journal of Medical Genetics.

Genetic variants reduce risk of Alzheimer's disease
A DNA study of over 10,000 people by UCL scientists has identified a class of gene variants that appear to protect against Alzheimer's disease.

Rare genetic variants predispose to sudden cardiac death
By identifying rare DNA variants that substantially increase risk of sudden cardiac death, researchers have laid the foundation for efforts to identify individuals who could benefit from prevention strategies prior to experiencing symptoms.

Genetic variants for autism linked to higher rates of self-harm and childhood maltreatment
People with a higher genetic likelihood of autism are more likely to report higher childhood maltreatment, self-harm and suicidal thoughts according to a new study by researchers at the University of Cambridge.

Genetic variants with possible positive implications for lifestyle
A German and British research team lead by the Technical University of Munich (TUM) has examined the interplay between genetics, cardiovascular disease and educational attainment in a major population study.

Read More: Genetic Variants News and Genetic Variants Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.